Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Adrenocortical response in influenza as a pattern for using corticosteroids in COVID-19

Breadcrumb

  • Home
  • Adrenocortical Response In Influenza As a Pattern For Using Corticosteroids In COVID-19
  • Adrenocortical response in influenza as a pattern for using corticosteroids in COVID-19

Irma Tha. Rass *

Center of Theoretical Problems of Physico-Chemical Pharmacology (until 2007), Moscow, Russia.
Research Article
GSC Biological and Pharmaceutical Sciences, 2020, 12(03), 098-101.
Article DOI: 10.30574/gscbps.2020.12.3.0267
DOI url: https://doi.org/10.30574/gscbps.2020.12.3.0267
Received on 15 August 2020; revised on 08 September 2020; accepted on 12 September 2020
In patients with influenza hospitalized during the epidemic (Moscow, 1977) blood levels of 11-oxycorticosteroids (11-OX) and tyrosine were determined. Due to specific features of tyrosine metabolism, its blood level is virtually determined by two factors: the functional competence of hepatocytes and tissue provision with glucocorticoids. Similar hypertyrosinemia was revealed in 11 patients with a severe complicated course of the disease and in 9 of 22 patients with a relatively light course of influenza. At virtually the same “intoxication start” the adrenocortical response was dramatically different in “severe” and “relatively light” patients: at the beginning of the disease in the “relatively light” patients there was a pronounced increase in the 11-OX level, whereas in the “severe” patients the level of 11-OX retained at the level normal for the physiological rest conditions. Thus, the clinical course of the acute infection was associated with the presence or absence of the well-timed adrenocortical response.
It seems that corticosteroid preparations would be most useful at the beginning of acute infection – as imitation of the full-value adrenocortical response. Possibly, the same would be useful for treatment of COVID-19.
 
Adrenocortical response; Acute influenza; Corticosteroid therapy; Analogy with COVID-19
 
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2020-…

Preview Article PDF

Irma Th. Rass. Adrenocortical response in influenza as a pattern for using corticosteroids in COVID-19. GSC Biological and Pharmaceutical Sciences, 2020, 12(3), 098-101. Article DOI: https://doi.org/10.30574/gscbps.2020.12.3.0267


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution